{
  "trial_id": "NCT00783393",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "histologically confirmed anaplastic astrocytoma on the tentorium at first relapse",
      "label": "met",
      "evidence": "MRI scan"
    },
    {
      "criterion": "unequivocal evidence of tumor recurrence or aggravation by MRI scan after treatment for initial onset",
      "label": "met",
      "evidence": "MRI scan"
    },
    {
      "criterion": "anaplastic astrocytoma diagnosed histologically by the last pathological diagnostic tests prior to initial administration of temozolomide",
      "label": "met",
      "evidence": "pathologic diagnosis report"
    },
    {
      "criterion": "tissue samples available for Central Pathologic Reviewer",
      "label": "met",
      "evidence": "available"
    },
    {
      "criterion": "MRI scan performed within 14 days before initial temozolomide administration",
      "label": "met",
      "evidence": "MRI scan"
    },
    {
      "criterion": "assessable tumor site confirmed by MRI",
      "label": "met",
      "evidence": "MRI scan"
    },
    {
      "criterion": "Age >=18 years, either sex, inpatients or outpatients",
      "label": "met",
      "evidence": "patient's age and status"
    },
    {
      "criterion": "Use of medically approved contraception methods in fertile subjects",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Karnofsky performance status >=70",
      "label": "met",
      "evidence": "patient's condition"
    },
    {
      "criterion": "Adequate clinically laboratory values obtained within 14 days before initial temozolomide administration",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "History of treatment with dacarbazine",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Subjects who received chemotherapy within 6 weeks before initial temozolomide administration",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Subjects who received interstitial radiotherapy or stereotactic radiosurgery",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Subjects who completed radiotherapy within 12 weeks before initial temozolomide administration",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Surgery at first relapse (including biopsy) within 1 week before initial temozolomide administration",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Subjects not recovered from acute toxicity due to previous therapy",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "45-year-old man with a history of anaplastic astrocytoma, severe lower extremity weakness and urinary retention",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT00783393",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_test10_top50"
  }
}